Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s arm receives USFDA approval for Sernivo Spray
>>
Dr. Reddy’s trades higher on the bourses
>>
Dr. Reddy’s gains on receiving USFDA tentative approval for Zenavod (doxycycline) Capsules
>>
Dr. Reddy’s receives USFDA tentative approval for Zenavod (doxycycline) Capsules
>>
Dr Reddys Laboratories informs about press release
>>
Dr. Reddy’s Lab shines on receiving USFDA approval for ZEMBRACE SymTouch injection
>>
Dr. Reddy’s Laboratories receives USFDA approval for ZEMBRACE SymTouch injection
>>
Dr Reddys Laboratories informs about quarterly statement of investor complaint
>>
Dr Reddys Laboratories informs about board meeting
>>
Dr. Reddy’s gains on relaunching Esomeprazole Magnesium Delayed-Release Capsules, USP
<<
<
102
103
104
...145
>
>>